Migraine is the most common cause of primary headache, affecting over 1 billion people worldwide, but the high burden of this pathology along with the lack of effective therapies have allowed the implementation of alternative therapies like acupuncture for managing this condition.
ObjectiveTo evaluate the impact and effectiveness of acupuncture in the management of migraine with or without aura based on scientific literature available until May 27, 2021.
Materials and methodsScoping review that include Pubmed, SCOPUS and 18 databases of the World Health Organization International Registry of Clinical Trials Platforms. Theoretical publications and clinical trials in English, Spanish and French were included.
Results84 documents and 62 clinical trials were included, where they evaluate acupuncture in settings of acute migraine attacks, as chronic prophylaxis in migraine and compared with drugs available for prophylaxis.
ConclusionAcupuncture is a safe, effective and cost-effective therapy in the management of acute migraine attacks and as prophylaxis for chronic migraine.
La migraña es una de las causas primarias de cefalea, afectando a más de un billón de personas a nivel mundial, pero, la alta carga de morbilidad de esta patología junto con la limitada efectividad de terapias ha llevado a la implementación de terapias como la acupuntura para su manejo.
ObjetivoEvaluar el impacto y efectividad de la acupuntura en el manejo de la migraña con o sin aura con base en una revisión de la literatura científica disponible hasta mayo 27 de 2021.
Materiales y métodosRevisión sistemática exploratoria que incluyó las bases de datos Pubmed, SCOPUS y 18 bases de estudios clínicos de la Organización Mundial de la Salud. Fueron incluidas publicaciones teóricas y ensayos clínicos cuyo idioma fuese español, inglés o francés.
ResultadosSe incluyeron 84 documentos y 62 ensayos clínicos, donde la acupuntura fue evaluada en ataques agudos de migraña y como profilaxis para la migraña crónica, además, fue comparada con las medicaciones disponibles.
ConclusiónLa acupuntura es una terapia segura, efectiva y costo-efectiva en el manejo tanto en los ataques agudos de migraña como profilaxis para la migraña crónica.
Migraine is a chronic illness that can range from moderate to severe - and might be disabling. According to the Global Burden of Disease Study 2016,1 it affects 1000 million people, locating this pathology as the second cause of disability worldwide. This condition has a complex pathophysiology, because it is an addition between genetic, epigenetic, and individual factors. Genetics have become a research point based on investigation findings, including a high penetrance, that can reach up to 70%,2 also, there is genetic susceptibility, showed by the rate of this condition in monozygotic twins,3 and, most recently, the work made by Gormely et al.4 shows 38 different loci related with migraine, most of them affecting muscular and vascular tissues, pointing to its neurovascular etiology.
Trigeminovascular system has been considered the source of nociceptive pain in migraine,5 where first-order neurons in this system are activated, and their afferent fibers reach the meninges and their vessels, these last where a high density of C-fibers and Aδ-fiber axons are found, explaining why when there is a mechanical or electrical stimulation of these vessels, can lead to a headache. First-order neuron axons can also reach the brain stem, sensitizing second-order neurons, including those in the spinal trigeminal nucleus, whose axons reach periorbital skin and pericranial muscles.5 Afterwards, axonal projections coming from second-order neurons6 reach the thalamus (cutaneous allodynia, headache exacerbation by light), brainstem (nausea, vomiting), hypothalamus (loss of appetite), upper cervical spinal cord (neck pain), and basal ganglia. This anatomy is very important, because when the trigeminovascular system is active, can lead to a parasympathetic outflow to the intracranial arteries,7 releasing molecules including pituitary adenylate cyclase-activating peptide (PACAP), calcitonin gene-related peptide (CGRP), and vasoactive intestinal polypeptide, producing a major vasodilation of these arteries, but also, a generalized neurogenic inflammation state.6,7
Migraine without aura is clinically characterized by8 at least 5 attacks of headache lasting between 4 and 72 h, which might be unilateral, with pulsating quality, moderate to severe in pain, and may cause avoidance of routine physical activity. Also, it can present with nausea and/or vomiting, photophobia, or phonophobia, and there are no other possible diagnoses (secondary cephalea has been ruled out). When migraine presents with aura,8 it presents as classic (without aura headache-type) but, it includes fully reversible aura symptoms (visual, sensory, speech, language, motor, brainstem, or retinal) plus, at least one aura symptom which spreads gradually over 5 min, at least one aura symptom is unilateral, also, at least one aura symptom is positive; aura symptoms last between 5 and 60 min, and they are followed by headache.
Acute treatment for migraine attacks is based on the severity of the pain, associated symptoms, onset, and duration of the headache.9 Non-steroidal anti-inflammatories (NSAIDs) are the first line for mild to moderate headache or in severe headache that have responded to this pharmacological group.7,10 Acetylsalicylic acid, ibuprofen, and diclofenac have shown the best effectiveness among NSAID.7 When there is no contraindication, triptans are the first line of management in severe attacks,9 and there are seven oral triptans available for clinical use,7 however, most of them have similar characteristics regarding efficacy, tolerability, and suitability.11 Combination of these medications has shown a higher rate of relief than using either one as monotherapy.10 But combinations are not limited to pain medications, management of migraines can include antiemetics, caffeine, and ergot derived.12
Preventive management is defined as therapy for reducing severity, duration, and frequency of migraine attacks,9 in patients with >4 attacks per month,9,12 but can be used in patients with poor response of medications during the acute attack, when the patient overuse analgesics and if the life quality is moderate/severely affected. Medications include non-selective beta blockers, antidepressants, calcium channel blockers, anticonvulsants, and some vitamins.9 But these medications have poor adherence, mostly due to their adverse effects and poor tolerance. Life-style recommendations and behavioral therapy are also recommended in patients with chronic migraine,7,9,11,12 but non-traditional (allopathic) therapies have risen as alternative management for this condition, including acupuncture. We aim this study to evaluate the impact and effectiveness of acupuncture in the management of migraine with or without aura.
Materials and methodsThis scoping review followed the steps proposed by Arksey, O’Malley13 and Levac,14 answering the questions: Is there any impact of acupuncture in the severity, duration, and frequency of migraine? Is there evidence regarding the effectiveness of acupuncture in the management of acute migraine attacks? And, if there is an impact of acupuncture in the life-quality in patients with migraine? Based on these three questions, a research protocol was developed for conducting this scoping review.
ProtocolBefore the beginning of this scoping review, there was a protocol developed based on the PRISMA-P guidelines for systematic reviews and scoping reviews15 (Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocol).
Inclusion and exclusion criteriaInclusion criteria were: 1. Theoretical publications (narrative reviews, systematic reviews, meta-analysis) or clinical trials. 2. The objective of the publication is to evaluate or discuss the impact/use of acupuncture in the management of migraine (with or without aura) (either in acute attacks or as preventive therapy). 3. The clinical trial / publication shows results regarding the use of acupuncture in patients with migraine (either in acute attacks or as preventive therapy). 4. Languages considered in this publication are English, Spanish, and French. All the publications that did not meet the criteria were excluded. There was no date limit in this research, with the last update on May 27, 2021.
Research strategyDatabases included were SCOPUS and Pubmed. Also, there were included registers from 18 databases from the International Clinical Trials Platform from the World Health Organization (WHO)16: Chinese Clinical Trial Registry, U.S. National Library of Medicine, German Clinical Trials Register (DRKS), Iranian Registry of Clinical Trials (IRCT), EU Clinical Trials Register (EU-CTR), Japan Primary Registries Network (JPRN), Australian New Zealand Clinical Trials Registry (ANZCTR), Brazilian Clinical Trials Registry (ReBec), ISRCTN, Peruvian Clinical Trial Registry (REPEC), Clinical Research Information Service (CRiS) - Republic of Korea, Clinical Trials Registry - India (CTRI), Cuban Public Registry of Clinical Trials RPCEC), The Netherlands National Trial Register (NTR), and Pan African Clinical Trial Registry (PACTR). Based on each data system, there were used keywords and boolean operators. The research algorithm is available on supplement 1.
Selection of publications and data collectionUsing Rayyan,17 a free website for managing systematic reviews, authors review and choose all possible titles and abstracts. Then, they were into meetings discussing and solving discrepancies. After that, they remove duplicates and get full documents through the Universidad de la Sabana and Universidad Nacional library.
Next step was data extraction. There were tables created based on the variables which will answer research questions, one table was used for clinical trial entries and another for the other kind of publications. Data was selected, described, and analyzed based on the method recommended by Arsey and O’Malley,13 making all the information extracted standard. The created formats were adjusted using 5% of the documents for assuring if the applied method was appropriate, then, the remaining information was extracted.
The information extracted from publications include authors, document-type (e.g., systematic review), objective, journal, country, and main findings. For clinical trials, information extracted included: ID code, recruitment state, country, sample size, intervention, control, primary outcome, starting/registered date, and completion date.
Integration and presentation of resultsThe results of this scoping review are shown following the categories proposed by Grudniewicz et al.,18 which include: a) a summary of the characteristics and distribution of the included publications, b) a summary of the results. As mentioned in the protocol, results will be presented using the PRISMA extension for scoping reviews (PRISMA-ScR).15 A checklist was developed, which was completed, and is included in the supplement 2.
ResultsIn this scoping review, a total of 84 documents were included (bibliography available in supplement 3) and 62 clinical trials (Fig. 1).
There are 62 clinical trials, including interventional parallel studies (n=52; 83.87%), interventional, single group assignment, non-blinded trials (n=6; 9.67%), case–controls study (n=1; 1.61%), prospective cohorts (n=2; 3.22%), and prospective observational study (n=1; 1.61%). These are mostly from China (n=34), followed by United States (n= 5), Iran (n=4), Germany (n=3), Japan (n=3), Brazil (n=3), Australia (n= 2), Spain (n=2), Taiwan (n= 2), Indonesia (n= 1), France (n=1), and Czech Republic (n=1). The total population evaluated is 9079 patients. The main outcomes evaluated are changes in frequency, intensity, and number of headaches after treatment. Most of them are completed (n=38), 9 studies are recruiting, 13 of them are active but not recruiting, 1 of them (UMIN000028222) has no available information in the clinical trial databases and the NCT01481103 trial was terminated by the main investigator, it was reported due personal circumstances. The principal features of these studies are available in Table 1. The biggest study (ISRCTN18249834) evaluates the efficacy of verum acupuncture compared with sham acupuncture and standard medical management.19 The primary outcome was the difference in migraine days in the period between 4 weeks before randomization and weeks 23–26 after randomization. Results shown a mean reduction of 2.3 days of headache in the verum acupuncture group (95% CI, 1.9–2.7), 1.5 days in the sham acupuncture group (95% CI, 1.1–2), and 2.1 days in the standard therapy group (95% CI, 1.5–2.7), but without statistical difference between all groups (p= <0.01). There was also no difference between the three treatment groups regarding secondary outcomes (p=<0.01). When compared between each other, there are no findings for suggesting physicians to choose one or another, however, if they are compared as in a non-inferiority trial, all treatments were effective improving in the number of migraine days, but with better results for verum acupuncture than sham acupuncture, mostly because sham acupoints were applied superficially on upper arms, thighs, and both scapulae, but they did not consider head or other specific acupoints for migraine. However, an interesting finding was that sham acupuncture was actually effective, showing that needles might have a biological effect similar to the verum acupuncture when it is applied to specific points.
Characteristics of the publications included in the scoping review.
Authors | Document | Objective | Year | Journal | Country | Main findings / Contributions |
---|---|---|---|---|---|---|
Ahn CB, et al. | Prospective cohort trial | Develop effective treatment using combined acupuncture (CA) - traditional acupuncture and ear acupuncture - and to set clinical protocols for future trials. | 2011 | Journal of Acupuncture and Meridian Studies | Korea | Traditional or combined acupuncture, was associated with a reduction in pain in headache, migraine, trigeminal neuralgia, and retroauricular pain in facial paralysis, but no significant differences between them. |
Alecrim-Andrade J, et al. | Randomized sham-controlled trial | Evaluate semi-standardized acupuncture efficacy in migraine prophylaxis. | 2006 | Cephalalgia | Brazil | Acupuncture shows no difference from sham acupuncture in preventing migraine attacks. No statistically significant difference about headache severity, frequency, or duration of migraine attack, either regarding associated symptoms or rescue medication. |
Alecrim-Andrade J, et al. | Prospective cohort trial | Assess the efficacy of acupuncture in migraine prophylaxis. | 2008 | The Clinical Journal of Pain | Spain | Real acupuncture group showed improvement with significant differences in the number of days with migraine and migraine attack frequency in the first and second months. In the last month of the treatment was presented a high improvement of the sham acupuncture group, these differences disappeared, |
Allais G, et al. | Randomized controlled trial | Evaluate the effectiveness of acupuncture versus flunarizine in the prophylactic treatment of migraine without aura. | 2002 | Headache | Italy | The number of attacks after 2 months of therapy and analgesic consumption were significantly lower in the Acupuncture group, with pain intensity significantly reduced and less side effects, but at 6 months no such differences existed between the two treatment groups. |
Allais G, et al. | Prospective cohort trial | Evaluate TENS, infrared laser therapy and acupuncture in the treatment of transformed migraine, | 2003 | Neurological Sciences | Italy | The headache days significantly decreased in the TENS and laser therapy groups in the first month, but this became significantly lower in the Acupuncture group after the second month. |
Allais G, et al. | Prospective randomized cohort trial | Verify the therapeutic value of area M and to compare it with an area of the ear which probably does not have a therapeutic effect on migraine attacks. | 2011 | Neurological Sciences | Italy | This study suggests that the therapeutic specificity of auricular points exists and is linked to the somatotopic representation of our body on the ear. |
Backer M, et al. | Prospective cohort trial | Evaluate the effect of repetitive somatosensory stimulation (acupuncture) on cerebrovascular response in migraineurs by functional transcranial Doppler. | 2004 | Headache | Germany | Data indicate that repetitive somatosensory stimulation (acupuncture) might positively influence the abnormal cerebrovascular response in migraineurs. In a subgroup of migraineurs, however, the dysfunction of the cerebrovascular system might deteriorate under the treatment. |
Bäcker M. et al. | Prospective cohort trial | Test whether the clinical effects of acupuncture in migraine prophylaxis are mediated by changes of the autonomic regulation. | 2008 | The Clinical Journal of Pain | Germany | Patients had a significant improvement in attack frequency, days with moderate or severe headache, and pain intensity, Verum acupuncture and sham acupuncture might have a beneficial influence on the autonomic nervous system in migraineurs, however, the mode of acupuncture did not have an influence on the clinical outcome. |
Cayir Y. et al. | Prospective cohort trial | Evaluate the effect of acupuncture on the serum matrix metalloproteinase-2 (MMP-2) level and activity in patients with migraine. | 2014 | Acupuncture in Medicine | Turkey | The mean VAS was 85.5±16.6 and was significantly decreased to 39.8±20.6 after 10 sessions of acupuncture, also, was a significant increase in quality-of-life score after acupuncture treatment. |
Ceccherelli F. et al. | Randomized, controlled, blind study | Compare the effectiveness of somatic and ear acupuncture for treatment of migraine without aura. | 2012 | Acupuncture & Electro-Therapeutics Research | Italy | At the end of therapy pain was significantly lower for both groups, but after six months residual pain was so different between somatic (16.8%) and ear (48.83%) acupuncture. A decrease of depression score was present in both groups. |
Chen YY, et al. | Meta-analysis | Compare acupuncture with propranolol using indirect treatment comparison meta-analysis. | 2020 | Journal of Neurology | China | Acupuncture was significantly better than propranolol, in reducing migraine frequency, with fewer migraine episodes and seemed to be better than flunarizine, metoprolol, propranolol+flunarizine, topiramate, and usual care; indirectly acupuncture was better than metoprolol in reducing migraine days. Acupuncture caused fewer adverse events than propranolol, but the difference did not reach statistical significance. |
Cohen MM, et al. | Multicentre, randomised, equivalence and non-inferiority trial | Assess analgesia provided by acupuncture, alone or in combination with pharmacotherapy, to patients presenting to emergency departments with acute low back pain, migraine, or ankle sprain. | 2017 | The Medical Journal of Australia | Australia | The effectiveness of acupuncture alone was comparable with that of pharmacotherapy. It may be useful as an adjunct to pharmacotherapy or when pharmacotherapy is unsuitable, but any therapy provides optimal acute analgesia during the first hour. |
Diener HC, et al. | Multicentre randomised controlled clinical trial | Assess the efficacy of verum acupuncture compared with sham acupuncture and standard migraine prophylaxis with beta blockers, calcium-channel blockers, or antiepileptic drugs in the reduction of migraine days. | 2008 | The Lancet Neurology | Germany | The mean reduction of migraine days was statistically significant compared with baseline, but not across the treatment groups (sham acupuncture, verum acupuncture, or standard therapy). |
Endres HG, et al. | Narrative Review | Look at current studies on acupuncture and migraine and discuss the results. | 2007 | Expert Review of Neurotherapeutics | Germany | A long-term pharmacological treatment for migraine prophylaxis is not superior to acupuncture treatment, the patients show a clinically relevant reduction in migraine symptoms compared with baseline, No significant difference was found between verum and sham acupuncture with respect to the reduction in the number of migraine days. |
Endres HG, et al. | Multicentre, sham-controlled, patient and observer-blinded, randomised trial | Investigate the effects on headache frequency of verum acupuncture vs. sham acupuncture, in patients with episodic or chronic TTH | 2007 | The Journal of Headache and Pain | Germany | TTH improves after acupuncture treatment, 33% of verum patients and 27% of sham controls were classed as responders. Verum was superior to sham acupuncture for headache days and the International Headache Society response criterion. |
Facco E, et al. | Prospective, randomized, controlled study | Check the effectiveness of a true acupuncture treatment in migraine without aura, comparing it to a standard mock acupuncture protocol, an accurate mock acupuncture healing ritual, and untreated controls. | 2008 | Headache | Italy | Data suggest that traditional acupuncture is an effective tool for migraine prophylaxis: the syndrome differentiation according to TCM seems to work, although we do not yet know whether all TCM syndromes are so relevant as to call for a specific acupoint selection. |
Facco E, et al. | Prospective, controlled study | Compare the effectiveness of traditional acupuncture and valproic acid in migraine prophylaxis. | 2013 | Minerva Anestesiologica. | Italy | Data show a lower pain intensity and lower Rizatriptan intake at six-months follow-up with no adverse events in acupuncture patients compared to those treated with valproic acid. |
Ferro EC, et al. | Randomized controlled trial | Investigate the efficacy and tolerability of acupuncture, Tanacetum or combined treatment on quality of life in women with chronic migraine. | 2012 | Acupuncture in Medicine | Brazil | Improvement of the quality of life and better analgesic effect of acupuncture combined with tanacetum treatment on migraine pain in women when compared with acupuncture or tanacetum alone. |
Foroughipor M. et al. | Prospective randomised cohort trial | Assess the effects of adding acupuncture to conventional migraine prophylaxis. | 2014 | Acupuncture in Medicine | Iran | Was a reduction in the number of attacks by both true and sham acupuncture, but this reduction was significantly greater in the true acupuncture group. The efficacy of acupuncture treatment gradually decreased over time so that the difference between the numbers of attacks was minimal at the end of the fourth month. |
Foster NE, et al. | Meta-Analysis | Analyzed the Acupuncture Trialists’ Collaboration dataset to identify subgroups of chronic pain patients who might be responsive to acupuncture compared to control treatments. | 2021 | Acupuncture in Medicine | United States | They did not find evidence to support the notion that there are exceptional acupuncture responders. The challenge remains to identify features of chronic pain patients that can be used to distinguish those that have a good response to acupuncture treatment. |
Giovanardi CM. et al. | Systematic Review | Assess the efficacy and safety of acupuncture for the prophylaxis of episodic or chronic migraine in adult patients compared to pharmacological treatment. | 2020 | Frontiers in Neurology | Italy | Reduction in favor of acupuncture for the number of days with migraine per month, pain intensity and the dropout rate due to any reason and due to adverse events. Long-term follow-up showed that acupuncture was better to reduce the frequency of migraine attack by month, disability and use of rescue medication. |
Gottschling S, et al. | Randomized Controlled Trial | Investigate whether laser acupuncture is efficacious in children with headache and if active laser treatment is superior to placebo laser treatment | 2008 | Pain | Germany | They conclude that laser acupuncture can provide a significant benefit for children with headache with active laser treatment being clearly more effective than placebo laser treatment. |
Jiang Y. et al. | Systematic Review | Evaluate the efficacy and safety of acupuncture for the treatment of migraine, and to confirm the effect of acupuncture for improving anxiety. | 2018 | Frontiers in Pharmacology | China | VAS scores were lower with acupuncture than with medication at 1–3 months after treatment and lower compared with sham acupuncture at 1 month. |
Li X. et al. | Systematic Review | Assess the clinical efficacy and safety of Electroacupuncture treatment for migraine as the basis for reliable clinical strategies for patients with migraine. | 2019 | The American Journal of Chinese Medicine | China | Electroacupuncture was superior to control treatment (Western medicine, sham-EA, blank control, acupuncture, and acupoint catgut embedding), with lower VAS score, frequency of headache attack, self-rating anxiety scale and self-rating depression score. |
Li Y, et al. | Randomized controlled trial | Discuss the results of a multicenter randomized controlled trial of the efficacy of verum acupuncture in treating acute migraine attacks. | 2009 | Headache | China | Verum acupuncture is more effective than sham acupuncture in reducing the discomfort of acute migraine. Verum acupuncture is also clearly effective in relieving pain and preventing migraine relapse or aggravation. Support that there are specific physiological effects that distinguish genuine acupoints from non acupoints. |
Li Y, et al. | Randomized controlled trial | Assess the efficacy of acupuncture at migraine-specific acupuncture points compared with other acupuncture points and sham acupuncture. | 2012 | Canadian Medical Association Journal | China | Patients in the acupuncture groups reported fewer days with a migraine compared with control. Was a significant, but not clinically relevant, benefit for almost all secondary outcomes (frequency of migraines, intensity of pain) in the three acupuncture groups, without relevant differences between the groups. |
Li Z, et al. | Prospective cohort trial | Explore how an effective treatment (verum acupuncture) could modulate the amplitude of low-frequency fluctuations of Migraine without Aura patients. | 2017 | NeuroImage: Clinical | China | Verum acupuncture showed significant improvement in VAS score and headache frequency, Verum and sham acupuncture modulates amplitude of low-frequency fluctuations of trigeminocervical complex in patients with migraine. |
Li Z, et al. | Randomized controlled trial | Investigate the resting-state functional connectivity (rs-fc) of the right frontoparietal network (rFPN) between migraineurs and healthy controls (HCs) in order to determine how the rFPN rs-fc can be modulated by effective treatment. | 2017 | Cephalalgia | China | Results suggest that migraineurs are associated with abnormal rFPN rs-fc. An effective treatment, such as acupuncture, may relieve symptoms by strengthening the cognitive adaptation/coping process. Elucidation of the adaptation/coping mechanisms may open up a new window for migraine management. |
Linde K, et al. | Randomized controlled trial | Investigate the effectiveness of acupuncture compared with sham acupuncture and with no acupuncture in patients with migraine. | 2005 | JAMA | Germany | The reduction of the mean days with moderate or severe headache was equal between acupuncture and sham acupuncture groups (-2.2 days), with 51% and 53% responders respectively, the reduction of days with headache in the waiting group was -0.8 days, with 15% responders. |
Linde K, et al. | Pooled analysis of randomized controlled trials | Investigate the influence of expectations on clinical outcome in trials of acupuncture in patients with migraine, tension-type headache, chronic low back pain, and osteoarthritis | 2007 | Pain | Germany | A significant association was shown between better improvement and higher outcome expectations. The odds ratio for response between patients considering acupuncture an effective or highly effective therapy and patients who were more sceptical was 1.67, for personal expectations and confidence after the third session, odds ratios were 2.03 and 2.35), respectively. |
Linde K. et al. | Narrative Review | Investigate acupuncture effectiveness versus routine care or sham acupuncture, in reducing headache frequency in patients with migraine. | 2009 | Cochrane | Germany | Patients receiving acupuncture had higher response rates and fewer headaches, compared to routine care only, There was no statistically significant superiority to true acupuncture over sham acupuncture. Acupuncture had slightly better outcomes and fewer adverse effects than prophylactic drug treatment. |
Linde K. et al. | Narrative Review | Investigate whether acupuncture is more effective than no prophylactic treatment/routine care only; than ’sham’ (placebo) acupuncture; and as effective as other interventions in reducing headache frequency in patients with episodic or chronic TTH | 2009 | Cochrane | Germany | They found statistically significant and clinically relevant short-term (up to 3 months) benefits of acupuncture over control for response, number of headache days and pain intensity. |
Linde K. et al. | Narrative Review | Investigate whether acupuncture is more effective than routine care only; sham acupuncture; and as effective as prophylactic drugs treatment in reducing headache frequency in adults with episodic migraine. | 2016 | Cochrane | Germany | Acupuncture was associated with a moderate reduction of headache frequency over no acupuncture, a small but statistically significant frequency reduction over sham acupuncture and a reduced migraine frequency versus drug prophylaxis. |
Linde M, et al. | Randomized placebo-controlled study | Examine the role of needling per se in acupuncture as prophylaxis for menstrual-related migraine | 2005 | Cephalalgia | Sweden | No significant differences were found between the verum and the placebo groups, either in the attack frequency or in the number of days per month with migraine, headache intensity or drug-use. |
Liu J, et al. | Double-blinded, randomized, placebo-controlled trial | Investigate the brain structural and functional changes for migraine attacks, and if it could predict placebo hypoalgesia | 2017 | Human Brain Mapping | China | Individual differences for the brain structure in the pain modulatory system is related to how an individual facilitated or diminished hypoalgesia responses to placebo treatment in migraineurs. |
Lo MY, et al. | Systematic review | Review the cerebral hemodynamics involved in acupuncture and migraine headache, elucidated by modern brain imaging techniques. | 2013 | Journal of Traditional and Complementary Medicine | Taiwan | Acupuncture may positively influence cerebral autoregulation during the interictal phase. Needling at angles connecting acupoints may be clinically superior to standard acupuncture. |
Lo MY, et al. | Systematic review | Review the literature investigating the effect of acupuncture on muscular and/or cerebral microcirculation. | 2015 | Evidence-Based Complementary and Alternative Medicine | Taiwan | Acupuncture influences regional oxygen saturation in cerebral and muscular tissue. Acupuncture may modulate dysfunction in cerebral autoregulation. |
Meissner K, et al. | Systematic Review | Investigate whether different types of placebo treatments are associated with different responses | 2013 | JAMA Internal Medicine | Germany | Sham acupuncture and sham surgery were associated with a more pronounced reduction of migraine frequency than oral pharmacological placebos |
Melchart D, et al. | Narrative Review | Determine whether acupuncture is more effective than no treatment, ’sham’ (placebo) acupuncture and as effective as other interventions used to treat idiopathic (primary) headaches. | 2001 | Cochrane | Germany | True acupuncture was reported to be significantly superior in migraine and tension-type headache patients. |
Melchart D, et al. | Randomized controlled trial | Investigate whether acupuncture is superior to placebo and equivalent to sumatriptan for the early treatment of an acute migraine attack. | 2003 | Journal of Internal Medicine | Germany | Acupuncture and sumatriptan were more effective than a placebo injection in the early treatment of an acute migraine attack. Sumatriptan was more effective than acupuncture at relieving headache. |
Nie L, et al. | Randomized controlled assessor-blind clinical trial | Explore the effectiveness of acupuncture combined with tui na therapy in patients with migraine. | 2019 | Complementary Medicine Research | China | The total effective rate of acupuncture with tui na treatment was 95.6%, acupuncture 88.9%, and 75.6% for control group (flunarizine hydrochloride, with a significant reduction in attack frequency, severity of pain, duration of migraine, and associated symptoms. |
Ou MQ, et al. | Systematic review | Investigate the efficacy and safety of acupuncture for migraine, and transcranial doppler changes after acupuncture. | 2020 | Frontiers in Neurology | China | Acupuncture was more effective than sham acupuncture and medication groups, with greater improvement in VAS score and lower adverse reaction rate. About improvement of intracranial blood flow the results were heterogeneous and unreliable. |
Park J,et al. | Narrative Review | Summarize information from the Society for Acupuncture Research with studies on low back pain, knee osteoarthritis, migraine, tension-type headache, neurological conditions, psychiatric disorders, and functional bowel disorders. | 2008 | The Journal of Alternative and Complementary Medicine | United States | Verum acupuncture was at least as effective as migraine prophylaxis with beta blocker, with less number of headache days (the differences between verum and sham acupuncture was not significant). Patients receiving acupuncture took less medication. |
Streng A, et al. | Prospective randomized cohort trial | Investigate whether acupuncture is as effective and safe as metoprolol in the prophylactic treatment of migraine | 2006 | Headache | Germany | The reduction in the number of migraine days and the proportion of responders was better in the acupuncture group, with fewer adverse effects, but results were not significant. |
Sun Y, et al. | Systematic Review | Evaluate the efficacy of acupuncture for treatment of chronic headache. | 2008 | Anesthesia & Analgesia | England | Needling acupuncture is superior to sham acupuncture and medication therapy in improving headache intensity, frequency, and response rate. |
Tastan K, et al. | Prospective cohort trial | Investigate the effect of acupuncture, hypnotherapy, and pharmacotherapy in migraine treatments | 2018 | International Journal of Clinical and Experimental Hypnosis | Turkey | The percentage reduction in the MIDAS (disability) and VAS (pain) scores at the third month in the acupuncture and hypnotherapy groups was significantly higher than that of the pharmacotherapy group. |
Trinh KV, et al. | Systematic review | Verify the efficacy of the conventional treatments used in Linde et al.’s 2016 comparison with acupuncture. | 2019 | Medical Acupuncture | Canada | Moderate evidence suggests that acupuncture is at least non-inferior to conventional treatments. |
Vickers AJ, et al. | Randomized, controlled trial | Determine the effects of acupuncture on headache, health status, days off sick, and use of resources in patients with chronic headache. | 2004 | BMJ | United States | Acupuncture leads to persisting, clinically relevant benefits for patients with chronic headache, particularly migraine, with less headaches days per year, best headache score, and health status based on physical role functioning, energy, and health changes. |
Wallasch TM, et al. | Randomized Controlled Trial | Evaluate the effect of acupuncture on cerebrovascular response in migraineurs by transcranial Doppler ultrasound. | 2012 | The Journal of Alternative and Complementary Medicine | Germany | Prophylactic treatment of migraineurs by standardized acupuncture might positively influence the dysfunction of the cerebrovascular response to autonomic stimuli, but not the cerebral vasotonus during rest. |
Wang LP, et al. | Single-blinded, double dummy, randomized controlled trial | Evaluate the efficacy of acupuncture for migraine prophylaxis. | 2011 | Pain | China | The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (flunarizine + sham acupuncture), No significant differences in reduction of pain intensity and improvement of the quality of life. |
Wang LP, et al. | Multicenter Single Blinded, Randomized Controlled Trial | Investigate the efficacy of acupuncture for acute migraine attacks compared with sham acupuncture. | 2012 | Pain Medicine | China | Verum acupuncture group was superior to sham acupuncture group on relieving pain and reducing the usage of acute medication. |
Witt CM, et al. | Meta-Analysis | Evaluate the impact of possible moderators on the effect of acupuncture treatment. | 2019 | The Clinical Journal of Pain | Switzerland | Patients reporting more severe pain at baseline experience more benefit from acupuncture compared to either sham-control or non-acupuncture control. |
Xu J, et al. | Systematic review | Assess the therapeutic and preventive effect of acupuncture and its safety for migraine without aura. | 2018 | Journal of Integrative Medicine | China | Acupuncture had a significant advantage over medication in reducing frequency of migraine and better VAS score over medication and sham acupuncture, with less side effect reports. |
Xu S, et al. | Multicenter, randomized clinical trial | Assess the efficacy of manual acupuncture as prophylactic treatment for patients with episodic migraine without aura. | 2020 | BMJ | China | Manual acupuncture resulted in a significantly greater reduction in the number of migraine days and in migraine attacks. |
Yang CP, et al. | Randomized clinical trial | Investigate the efficacy and tolerability of acupuncture compared with topiramate treatment in chronic migraine prophylaxis. | 2011 | Cephalalgia | Taiwan | A significantly larger decrease in the mean monthly number of moderate/severe headache days was observed in the acupuncture group compared with the topiramate group, with greater percentage of responders, and greater improvement in health-related quality of life. |
Yang CP, et al. | Randomized controlled trial | Identify predictive factors of outcome in patients with chronic migraine treated with acupuncture or topiramate | 2013 | The Clinical Journal of Pain | Taiwan | Patients with throbbing symptoms had better prognosis with acupuncture than those without throbbing. Higher scores in the general expectations for improvement predicted better responses in both treatment groups. |
Yang J, et al. | Prospective randomized cohort trial | Investigate acupoint specificity. | 2012 | BMC Complementary and Alternative Medicine | China | Acupuncture stimulation of different points on similar body regions in migraine patients reduced pain and induced different levels of cerebral glucose metabolism in pain-related brain regions. These findings may support the functional specificity of migraine- treatment-related acupoint. |
Yang M, et al. | Prospective randomized cohort trial | Investigated the brain metabolism changes of acupuncture analgesia induced by sub-specific acupoint and non-acupoint stimulation. | 2014 | Journal of Translational Medicine | China | Acupuncture stimulation at both sub-specific acupoint and non-acupoint yields ameliorating effect to migraine pain, but with evidently different patterns of brain glucose metabolism. |
Yang M, et al. | Systematic review | Assess the efficacy of acupuncture on the frequency and pain intensity of menstrual migraine. | 2020 | BMJ Supportive & Palliative Care | China | Acupuncture was not superior to sham acupuncture in reducing monthly migraine frequency and duration, average headache intensity, and analgesic use |
Yang Y, et al. | Systematic review | Identify the effectiveness of verum manual acupuncture compared with sham acupuncture for the treatment of migraine. | 2016 | Acupuncture in Medicine | China | Verum manual acupuncture was better than sham acupuncture with reduction in the recurrence rate, but no significant differences in headache intensity, frequency or duration, accompanying symptoms and use of medication. |
Yu X, et al. | Prospective randomized and controlled cohort trial | Make comparisons between acupuncture and acupressure for preventing menstrual migraine. | 2018 | Journal of Acupuncture and Meridian Studies | Canada | Verum acupuncture and acupressure were more effective for reducing menstrual migraine days and peak pain during intervention, but not significant differences during the follow-up. |
Zhang N ,et al. | Systematic review | Compare the effectiveness of acupuncture treatment with conventional migraine preventative medications. | 2020 | Headache | United States | Acupuncture is just as effective and has fewer side effects than many of the standard pharmaceutical agents. But the heterogeneity of the studies limits the analysis. |
Zhang Y ,et al. | Prospective cohort trial | Investigate the modulatory effect of acupuncture on the resting-state functional connectivity of brain regions in migraine without aura patients. | 2016 | Chinese Journal of Integrative Medicine | China | Acupuncture treatment could increase the functional connectivity of brain regions in the intrinsic decreased brain networks in migraine without aura patients. |
Zhao L, et al. | Multicentre randomized controlled trials | Investigated the adverse events associated with acupuncture, to assess the safety of acupuncture | 2011 | Trials | China | Acupuncture is a safe therapy with low risk of adverse events in clinical practice, including subcutaneous hematoma, bleeding, skin bruising and needle site pain. The risk factors for adverse events were related to the patients’ gender and age and the local anatomical structure of the acupoints. |
Zhao L, et al. | Randomized Controlled Trial | Compare the differences in brain activities evoked by active acupoints and inactive acupoints and to investigate the possible correlation between clinical variables and brain responses. | 2014 | PLOS ONE | China | The decrease in the VAS was related to the increased average regional homogeneity values in the anterior cingulate cortex and in the insula. Acupuncture might have the potential effect of regulating some disease-affected key regions and the pain circuitry for migraine. |
Zhao L,et al. | Randomized Clinical Trial | Investigate the long-term effects of true acupuncture compared with sham acupuncture and being placed in a waiting-list control group for migraine prophylaxis. | 2017 | JAMA Internal Medicine | China | The mean change in frequency of migraine attacks decreased in the true acupuncture group by 3.2, in the sham acupuncture group by 2.1, and the waiting-list group by 1.4; true acupuncture may be associated with long-term reduction in migraine recurrence. |
Zheng H, et al. | Secondary analysis of a Prospective cohort trial | Study whether a higher expectation of acupuncture is associated with better outcome improvements in patients with migraine. | 2015 | Acupuncture in Medicine | China | A high level of expectation after acupuncture treatment rather than at baseline was associated with better long-term outcome improvements in patients with migraine. |
Uritz et al. | Narrative review | overview of the acupuncture as treatment of acute and chronic migraine | 2020 | Neurology and Therapy | United States | Acupuncture might be useful as treatment for migraine patients due to its measurable effects on both the duration and frequency of migraine attacks |
Yin T, et al | Research article | Explore if the neuroimaging markers could predict the relief of the symptoms of patients with migraine MWoA following a 4-week acupuncture treatment. | 2020 | Frontiers in neurology | China | Demonstrated the feasibility and validity of applying machine learning technologies and individual cerebral spontaneous activity patterns to predict acupuncture treatment outcomes in patients with MWoA. |
Luo W, et al | Research article | Investigate the modulation effects of continuous taVNS at acupoints on the functional connectivity of the bilateral amygdalae in MwoA. | 2020 | Neural Plasticity | China | Continuous taVNS at acupoints can modulate the functional connectivity between the bilateral amygdala and pain-related brain regions in MwoA, involving the limbic system, default mode network, and pain matrix, with obvious differences between the left amygdala and the right amygdala. |
Li K, et al. | Research article | Examine the treatment-related effects of standard acupuncture treatment on the right frontoparietal network in migraine patients. | 2015 | The Journal of Headache and Pain | China | Their study provided new insights into the treatment-related neural responses in MWoA patients and suggested potential functional pathways for the evaluation of treatment in MWoA patients. |
Biçer M, et al | Clinical trial | Investigate the efficacy of acupuncture in preventing migraine attacks. | 2017 | Turkish Journal of Physical Medicine and Rehabilitation | Turkey | Acupuncture may be an effective option in the migraine prophylaxis. |
Zhen F, et al. | Clinical trial | Observe the clinical effects of electroacupuncture for migraine without aura. | 2014 | Journal of Acupuncture and Tuina Science | China | Electroacupuncture is an effective therapy for migraine without aura. |
Quirico P, et al. | Clinical trial | Evaluate the effects of the insertion of PC 6 Neiguan and LR 3 Taichong acupoints on the cerebral blood flow in the middle cerebral artery. | 2014 | Neurological Sciences | Italy | Their data seem to suggest that these two acupoints have very different effects on cerebral blood flow. The insertion of PC 6 Neiguan probably triggers a vasodilation in the middle cerebral artery, while the pricking of LR 3 Taichong determines a rapid and marked vasoconstriction. |
Mayrink WC, et al. | Research article | Assess the effectiveness of acupuncture as an auxiliary analgesic treatment for chronic headaches and their influence on the quality of life. | 2018 | Journal of Acupuncture and Meridian Studies | Brazil | The true acupuncture group showed greater effectiveness in reducing the intensity of pain, the number of crisis, the quantity of analgesics used, and improving the quality of life in patients with chronic headache, compared to sham acupuncture. |
Park KH, et al. | Clinical trial | Study blood flow in extracranial arteries after performing Korean Hand Acupuncture therapy on migraine patients. | 2009 | MEDICAL ACUPUNCTURE | Korea | Acupuncture can modulate extracranial blood flow through collateral circulation, which may affect the intracranial blood flow in migraine patients. |
Zou Y, et al. | Research article | To determine whether and how longitudinal acupuncture modulates the impaired default mode network in chronic migraine patients without aura. | 2019 | Hindawi Neural Plasticity | China | In patients with migraine there is an altered default mode network, and after acupuncture therapy there is regulation and normalization of this network that might be employed as a monitor of chronic migraine. |
Ning Y, et al. | Prospective cohort trial | Study the modulatory effects of acupuncture on the amplitude of low frequency fluctuations in migraine without aura patients. | 2017 | International Journal of Clinical and Experimental Medicine | China | Needling GB41 could change the amplitude of the intrinsic cortical activity of the brain, related to the amplitude of low frequency fluctuations abnormalities in migraine without aura patients. |
Allais G, et al. | Clinical trial | Identify the most important auricular zones for pain control by applying the needle contact test. | 2010 | Neurological Sciences | Italy | The most effective tender points in pain control were located on the antero internal part of the antitragus, the anterior part of the lobe and the upper auricular concha ipsilateral to the side of pain. |
Gong J, et al. | Prospective cohort trial | Observe the clinical efficacy of electroacupuncture with different frequencies in treating migraine. | 2021 | Journal of Acupuncture and Tuina Science | China | Variable frequency compared with low frequency and high frequency electroacupuncture shows superior clinical efficacy in treating migraine. |
Yang X-J, et al. | Prospective cohort trial | Investigate the use of imaging biomarkers to predict the outcome of acupuncture in patients with migraine without aura. | 2020 | Frontiers in Neurology | China | Pre-treatment brain structure could be a novel predictor of the outcome of acupuncture in the treatment of migraine without aura. |
Ni X, et al. | Systematic review | To review the effectiveness of acupuncture in the treatment of migraine compared with other treatments | 2020 | Journal of Pain Research | China | There is a minimum effectiveness of acupuncture as management of migraine, however the evidence is still limited due to the low quality of the published studies. |
Hesse J, et al. | Comparative, randomized trial | To compare the effects of dry needling of myofascial trigger points in the neck region to metoprolol in migraine prophylaxis. | 1994 | Journal of Internal Medicine | Denmark | Acupuncture can be considered as prophylaxis treatment in chronic migraine if metoprolol fails or has a contraindication for its use. |
Gu T, et al. | Clinical trial | To investigate if there is a neurochemical response to acupuncture treatment | 2018 | Journal of Pain Research | Canada | An increase in N-acetylaspartate/creatine was observed in bilateral thalamus in migraine without aura after the acupuncture treatment, which was correlated with the headache intensity score |
Notes: TENS: Transcutaneous electrical nerve stimulation - TTH: Tension-type headache - TCM: Traditional Chinese Medicine - rFP: right frontoparietal network - rs-fc: resting-state functional connectivity - VAS: visual analogue scale - MIDAS: Migraine Disability Assessment - MWoA: Migraine without aura - taVNS: transcutaneous auricular vagus nerve stimulation.
Yang et al.20 evaluated the impact of traditional acupuncture on migraine without aura. The primary outcomes of this trial included difference in the visual analogue scale (VAS) after the treatment and the brain glucose metabolism evaluated with a PET-CT scan, results were compared with patients subjected to electroacupuncture, and patients with no treatment. VAS pain intensity was reduced by traditional acupuncture (p=0.0005) and by electroacupuncture (p=0.008), but there was no significant reduction in pain intensity in patients with no treatment (p= 0.047). Regarding PET-scan results, when patients were subjected to traditional acupuncture, metabolism was increased when compared to patients with migraine but without treatment, in the middle temporal cortex, insula, middle frontal gyrus, precuneus, orbital frontal cortex, and middle cingulate cortex. It was also found that metabolism was decreased in parahippocampus, hippocampus, fusiform gyrus, postcentral gyrus, and cerebellum. These findings suggest that acupuncture can model the pain matrix within the brain and generate an important pain modulation through endogenous opioid modulation (orbital frontal cortex), and pain processing (hippocampus and insula), suggesting acupuncture can be an alternative treatment in patients with migraine without aura.
But trials were not only limited to evaluate its application in the outclinic patient, Cohen et al.21 evaluated the impact of acupuncture in the emergency room, as pain management of ankle sprain, low back pain, and migraine. The evaluation compared acupuncture alone, acupuncture plus pharmacological management, or standard care, but they found migraine unlike the other two conditions, neither statistical analyses indicated equivalence, nor non-inferiority. All therapies showed a decrease in the pain scale score after the beginning of the treatment, with a mean decrease of 2.1 points in VAS scale, and after the first hour, a decrease achieved 6.4 units, but there was no statistical significance between any therapy (p=0.57). Also, it is good to point out that none of the therapies successfully afforded patients in the emergency department, because most of them after the first hour had a VAS >4, and less than 40% had at least a 2-point VAS decrease, however, acupuncture alone was the only therapy that patients would repeat as management of any of these conditions, when compared with pharmacological management (47%–61% vs. 57%–52%). Acupuncture alone was also the therapy that actually needed more rescue dose (oral opioid offered in this study), but there cannot be established if acupuncture by itself failed as treatment or patients felt they had missed out on standard care, but regardless this situation, acupuncture can be a safe and useful alternative in the ER setting, in the multi-modal approach for pain management as a non-pharmacological therapy, but also, its implementation can increased the patient satisfaction when there are contraindications for certain drugs.
Documents includedA total of 84 documents were selected for this scoping review, including clinical trials (n=34; 40.47%), prospective cohort trials (n=18; 21.42%), systematic reviews (n=14; 16.66%), narrative reviews (n=7; 8.3%), research articles (n=5; 5.95%), meta-analysis (n=3; 3.57%), non-inferiority trial (n=1; 1.19%), pooled analysis of randomized controlled trial (n=1; 1.19%), and secondary analysis of a prospective cohort trial (n=1; 1.19%). Authors were mostly from China (n=32), followed by Germany (n=16), Italy (n=9), United States (n=5), Taiwan (n=4), Brazil (n=3), Turkey (n=3), Canada (n=3), Korea (n=2), Australia (n=1), Sweden (n=1), Iran (n=1), Spain (n=1), Denmark (n=1), Switzerland (n=1), and England (n=1). Main findings from these documents are available in Table 2.
Characteristics of the clinical trials included in the scoping review.
ID | Trial design | Country | Sample size | Intervention | Control | Primary outcome | Overall trial start/registered date | Expected trial end date |
---|---|---|---|---|---|---|---|---|
ChiCTR2100044251b | Interventional study, parallel, randomized non-blinded | China | 60 | Insertion point | Needle shallow stab non-point | - Change in the number of monthly headache onset | July 1, 2020 | June 30, 2023 |
ChiCTR2100042963 b | Interventional study, parallel, randomized, double-blinded | China | 156 | Acupuncture treatment group of migraine senior physicians | Migraine acupuncture treatment group of junior physicians | - Days of headache- Number of headache attacks | March 14, 2021 | November 30, 2023 |
ChiCTR2100042915 b | Interventional study, non-randomized, prospective cohort | China | 108 | Migraine acupuncture treatment group | Tension-type headache acupuncture treatment group | - Number of headache days- Number of headache attacks | February 22, 2021 | November 30, 2023 |
ChiCTR2000034417 b | Interventional study, parallel, randomized, non-blinded | China | 66 | Acupuncture treatment | Flunarizine | - Frequency of migraine attacks- Intensity of migraine- fMRI- Gut microbiota | August 15, 2015 | December 31, 2022 |
ChiCTR2000033995 b | Interventional study, parallel, randomized, non-blinded | China | 278 | True acupuncture group | - Sham acupuncture group- health control group | - Change in frequency of migraine attacks- Brain functional magnetic resonance data | July 1, 2020 | July 1, 2022 |
ChiCTR2000033040 a | Interventional study, parallel, randomized, double-blinded | China | 60 | - Arm 1: dry needling myofascial trigger points- Arm 2: dry needling myofascial trigger points and medication | - Medication | - Headache | September 1, 2019 | September 30, 2022 |
ChiCTR2000032854 b | Interventional study, parallel, randomized, non-blinded | China | 212 | acupuncture/Chinese medicine | Flunarizine | - Number of headaches per month | November 1, 2019 | November 30, 2021 |
ChiCTR2000032795 b | Interventional study, factorial, non-randomized, non-blinded | China | 30 | Acupuncture | None | - Magnetic resonance spectrum data | January 1, 2020 | December 31, 2021 |
ChiCTR2000032629 a | Interventional study, parallel, randomized, non-blinded | China | 60 | Acupuncture Trigger Pain Points | Nerve block | - Headache score after treatment- Overall efficacy- Headache grading after treatment | May 6, 2020 | December 1, 2020 |
ChiCTR2000032308 b | Interventional study, parallel randomized, single blinded | China | 194 | Real acupuncture | Sham acupuncture | - Frequency of migraine attacks | December 1, 2019 | December 31, 2022 |
ChiCTR1900028105 b | Interventional study, parallel, randomized, non-blinded | China | 135 | Arm 1: TCM combined with acupuncture of Qing-Gan Xie-HuoArm 2: TCM combined with routine acupuncture | Herbal intervention | - Headache score | July 1, 2018 | June 30, 2021 |
ChiCTR1900026046 a | Interventional study, parallel, randomized, double blinded | China | 108 | the verum auricular acupuncture | the sham-auricular acupuncture | - Frequency of migraine attacks | October 1, 2019 | March 30, 2020 |
ChiCTR1900025132 a | Interventional study, parallel randomized, single blinded | China | 140 | Arm 1: AcupunctureArm 2: Sham acupuncture | Arm 1: Healthy patientsArm 2: Flunarizine | - Intestinal flora data collection and processing-fMRI-Headache diary- HIT-6-SF-MPQ | July 31, 2019 | December 31, 2022 |
ChiCTR1900023105 a | Interventional study, parallel, randomized, double blinded | China | 120 | 4 groups: Implementation of acupuncture in the main and fixed points with or without electric needle once a week | 4 groups: Implementation of acupuncture in the main and fixed points with or without electric needle twice a week | - Number of days the headache occurred- Headache level | July 1, 2018 | June 30, 2021 |
ChiCTR1800019502 a | Interventional study, parallel, randomized, non-blinded | China | 90 | modified Wu-Zhu-Yu decoction companied with acupuncture at shaoyang acupoint | modified Wu-Zhu-Yu decoction | - Frequency of migraine attacks | July 1, 2018 | June 30, 2020 |
ChiCTR1800017259 b | Interventional study, parallel randomized, single blinded | China | 129 | Arm 1: Electroacupuncture treatment of 2HzArm 2: Electroacupuncture treatment of 100Hz | Non-acupoint acupuncture | - Frequency of migraine attacks | August 1, 2018 | December 31, 2020 |
ChiCTR-INR-17010760 a | Interventional study, parallel, randomized, non-blinded | China | 152 | Arm 1: Auricular needling at TF4, AH6, CO15 of CO10, CO12, CO15 alternatively twice a weekArm 2: Auricular needling at A-shi points twice a week | Arm 3: Auricular needling at A-shi points twice a week.Arm 4: Sham-auricular needling at A-shi points twice a week | - Comparing intensity reduction among 4 groups from 9th to 12th week- Comparing frequency reduction among 4 groups from 9th to 12th week | April 1, 2016 | December 31, 2017 |
ChiCTR-IOR-16008001 a | Prospective Observational Study, randomized, parallel | China | 40 | Balance Acupuncture Treatment | Acupuncture point | - fMRI | July 1, 2015 | June 30, 2016 |
ChiCTR-TRC-11001813 c | Interventional study, parallel, randomized, non-blinded | China | 30 | Arm 1: specific stimulation of traditionalacupointsArm 2: non-specific stimulation | No treatment | - Metabolism of glucose in the brain- Visual Analogue Scale(VAS) variation | July 1, 2008 | September 30, 2009 |
ChiCTR-IOR-15007495 b | Interventional study, parallel, randomized, non-blinded | China | 60 | Acupuncture (target disease migraine) | Arm 1: Acupuncture (target disease insomnia)Arm 2: Acupuncture (normal puncture in meridian points) | - VAS Scale- Headache Rating | March 31,2015 | December 1, 2016 |
ChiCTR-TRC-14004842 c | Interventional study, parallel, randomized, non-blinded | China | 210 | Acupuncture | Arm 1: Sham AcupunctureArm 2: No intervention | - Headaches days per month- Migraine frequence | October 1, 2014 | October 1, 2017 |
ChiCTR-TRC-10000807 c | Interventional study, parallel randomized, single blinded (investigators) | China | 90 | Acupuncture (shallow puncture in meridian points) | Arm 1: acupuncture (normal puncture in meridian points)Arm 2: acupuncture (normal puncture in meridian points) | - Number of migraine outbreak days per month | October 1, 2010 | December 31, 2012 |
ChiCTR-TRC-13003635 c | Interventional study, parallel, randomized, non-blinded | China | 60 | Acupuncture at active acupoints | Arm 1: acupuncture at inactive/placebo acupointsArm 2: acupuncture at acupoints on other meridians | - Headache diar | June 18, 2012 | June 18, 2014 |
ChiCTR-TRC-07000024 c | Interventional study, parallel, randomized, double blinded | China | 600 | Arm 1: Selection of puncture points will depends on the "Zheng". Electronic stimulatingArm 2: Superficial puncture without "De Qi" and no electronic stimulatingArm 3: Selection of acupuncture points and puncture methods based on WHO recommendation. Electronic stimulating | Anti-pain treatment by medicine | - Frequency of headache- Rate of no improvement | January 1, 2008 | December 31, 2010 |
NCT04766762 b | Interventional study, parallel, randomized, double blinded | China | 96 | Acupuncture combined with placebo | Sham acupuncture combined with flunarizine hydrochloride | - Changes in pain intensity- Changes in number of migraine attacks per 4 weeks | February 23, 2021 | February 28, 2023 |
NCT01152632 c | Interventional study, parallel, randomized, double blinded | China | 100 | Arm 1: Specific points of Bladder meridian and Shanjiao meridianArm 2: Non-specific points of Bladder meridian and Shanjiao meridianArm 3: Specific points of Stomach meridian | non-acupoints | - Improvement of headache frequency (within 4 weeks) | June 29, 2010 | December 2, 2014 |
NCT00714727 c | Interventional, single group assignment, non-blinded | United States | 50 | Acupuncture | N/A | - Reduction of frequency and intensity of headaches | July, 2008 | January, 2011 |
NCT04542811 c | Interventional, single group assignment, non-blinded | Turkey | 84 | Acupuncture | N/A | - Monthly attacks frequency- Duration of attacks- Pain severity | March 1, 2018 | September 30, 2018 |
NCT00599586 c | Interventional study, parallel, randomized, triple blinded | China | 480 | Arm 1: specific acupoints of Shaoyang meridiansArm 2: Non-specific acupoints of Shaoyang meridians | Arm 1: Acupoints of other meridiansArm 2: Non-acupoints | - Number of days with migraine- Frequency of migraine attacks | January 24, 2008 | June 29, 2010 |
NCT01481103 e | Interventional, single group assignment, non-blinded | United States | 9 | Acupuncture | Over-the-counter medication | - Number and intensity of migraine headaches | July, 2011 | April, 2013 |
NCT02765581 c | Interventional study, parallel, randomized, double blinded | China | 150 | Verum acupuncture | Arm 1: Sham acupunctureArm 2: Standard treatment | - Change in the number of migraine days- Change in the frequency of migraine attacks | May 6, 2016 | November 20, 2018 |
NCT02764996 c | Interventional, single group assignment, non-blinded | United States | 26 | Acupuncture | N/A | - Reduction of migraine headache pain | May 6, 2016 | June 30, 2017 |
NCT04157192 b | Interventional study, parallel, randomized, double blinded | France | 40 | Acupuncture | Sham acupuncture | - Regional homogeneity map in Interventional group patients before and after the first real acupuncture session.- Regional homogeneity map in Placebo group patients before and after the first real acupuncture session.- Regional homogeneity map in Interventional group patients before and after the last real acupuncture session.- Regional homogeneity map of Placebo group patients before and after the last placebo acupuncture session. | November, 2019 | June, 2021 |
NCT02681211 a | Interventional study, parallel, randomized, non-blinded | United States | 80 | Acupuncture | Medication + fluids | - Change in baseline pain score by a numerical self-reported visual analog pain score (VAS) | February 2016 | February 2022 |
NCT02580968 c | Interventional study, parallel, randomized, single-blinded | China | 2 | Electro-acupuncture | Flunarizine | - Migraine Disability Assessment Questionnaire (MIDAS) | March, 2015 | December, 2017 |
NCT01687660 c | Interventional study, parallel, randomized, non-blinded | China | 249 | Acupuncture | Sham acupuncture | - Frequency of migraine attacks | September, 2012 | September, 2014 |
NCT01096420 c | Interventional study, parallel, randomized, non-blinded | Taiwan | 68 | Acupuncture | Topiramate | - Mean monthly number of headache days with moderate or severe intensity | August, 2008 | August, 2010 |
NCT04509141 c | Interventional study, parallel, randomized, triple blinded | Indonesia | 34 | Acupuncture | Standard treatment | - Frequency, intensity and duration of headaches | July 5, 2019 | August 30, 2019 |
NCT04636359 c | Interventional study, parallel, non-randomized, triple blinded | China | 30 | Acupuncture(Patients in this group have the history of migraine without aura more than 5 years) | Acupuncture(Patients in this group have the history of migraine without aura equal or less than 5 years) | - Headache Intensity- Headache Days- Headache Frequency- Dataset of functional magnetic resonance imaging on brain | October 30, 2017 | February 1, 2020 |
NCT03503734 c | Observational, prospective cohort | Germany | 158 | Integrated headache care | N/A | - Headache frequency | August 18, 2011 | January 30, 2014 |
NCT03250754 c | Case-controls, retrospective | Spain | 482 | Electro-acupuncture | Pharmacological management | - Number of days with headache per month | March 20, 2017 | April 30, 2018 |
DRKS00009803 c | Interventional study, parallel, randomized, non-blinded | Czech Republic | 86 | Acupuncture + standard management | Standard management | -Frequency, duration and intensity of migraines | October 20, 2015 | December 15, 2017 |
IRCT201108097265N1c | Interventional study, parallel, randomized, single blinded | Iran | 100 | True acupuncture | Sham acupuncture | - Number of monthly headache attacks | March 1, 2011 | December 31, 2011 |
IRCT20200213046477N1 c | Interventional study, parallel, randomized, single blinded | Iran | 80 | Auricular acupuncture | Sham acupuncture | - Headaches | December 8, 2018 | October 23, 2019 |
IRCT20160813029327N17 c | Interventional study, parallel, randomized, non-blinded | Iran | 100 | Amitriptyline + propranolol + acupuncture | Amitriptyline + propranolol | - The average number of migraine attacks- Intensity- Duration of attacks- Nausea and Vomiting frequency | July 6, 2017 | April 30, 2018 |
IRCT201404146186N3 c | Interventional study, parallel, randomized, non-blinded | Iran | 100 | Acupuncture | Botox injection | - Pain intensity | April 30, 2014 | September 21, 2014 |
UMIN000043893 a | Interventional study, parallel, randomized, single blinded | Japan | 30 | Acupuncture | Sham acupuncture | - Headache Impact Test | March 25, 2021 | March 31, 2023 |
UMIN000028222 d | Interventional study, parallel, randomized, non-blinded | Japan | 40 | Acupuncture | Healthy control | - Headache Impact Test | July 7, 2017 | September 30, 2019 |
UMIN000005644 c | Interventional, single group assignment, non-blinded | Japan | 10 | Acupuncture | N/A | - Cerebral blood flow | July 22, 2011 | March 31, 2014 |
ACTRN12609000989246 c | Interventional study, parallel, randomized, single blinded | Australia | 528 | Acupuncture | Standard management | - Verbal Numerical RatingScale (VNRS)- Rescue therapy requirements in the ED | November 17, 2009 | December 10, 2015 |
ACTRN12605000314628 c | Interventional, single group assignment, non-blinded | Australia | 50 | Acupuncture | Sham acupuncture | - Frequency of migraine attacks- Duration of migraine attacks- Intensity of migraine attacks- Relief medication | September 6, 2005 | November 28, 2019 |
U1111-1190-6791 c | Interventional study, parallel, randomized, double blinded | Brazil | 34 | Acupuncture | Sham acupuncture | - The Verbal Number Scale (VNS)- Quality of life Questionnaire- The number of analgesics used- Number of attacks | January 1, 2016 | September 19, 2017 |
ISRCTN13563102 c | Interventional study, parallel, randomized, single blinded | China | 60 | Verum acupuncture + placebo medicine | Sham acupuncture + topiramate | - Monthly number of headache days | July 21, 2017 | August 31, 2020, |
ISRCTN11800433 c | Interventional study, parallel, randomized, single blinded | China | 100 | Verum acupuncture | Sham acupuncture | - The number of migraine days during the 4th and 16th week after randomization. | February 1, 2017 | February 1, 2019 |
ISRCTN35577064 c | Interventional study, parallel, randomized, double blinded | Taiwan | 60 | Verum acupuncture | Arm 1: Sham acupunctureArm 2: No acupuncture | - Headache frequency- Headache duration- Regional oxygenation of the cerebral cortex- Regional oxygenation of the upper trapezius | August 1, 2014 | July 31, 2017 |
ISRCTN98703707 c | Interventional study, parallel, randomized, non-blinded | Spain | 270 | Verum acupuncture | Arm 1: Sham acupunctureArm 2: Standard management | - The difference in the number of Days before and after treatment | February 1, 2008 | December 31, 2010 |
ISRCTN49839714 c | Interventional study, parallel, randomized, single blinded | China | 140 | Verum acupuncture + placebo medicine | Sham acupuncture + flunarizine | - Visual Analogue Scale (VAS) to assess the severity of migraine pain- Short-From of McGill Pain Questionnaire (SF-MPQ)- Change in frequency and duration of migraine attacks | June 1, 2007 | June 30, 2009 |
ISRCTN93327878 c | Interventional study, parallel, randomized, non-blinded. | Brazil | 37 | Verum acupuncture | Sham acupuncture | - The percentage of patients with a reduction of ≥50% in migraine attack frequency and the total of the migraine days compared with the baseline period. | December 7, 2001 | June 30, 2003 |
ISRCTN74335441 c | Interventional study, parallel, randomized, non-blinded | Brazil | 67 | Verum acupuncture | Sham acupuncture | - The percentage of patients with a reduction of ≥50% in migraine attack frequency and the total of the migraine days compared with the baseline period. | March 1, 2003 | January 30, 2003 |
ISRCTN52683557 c | Interventional study, parallel, randomized, non-blinded | Germany | 1295 | Verum acupuncture | Arm 1: Sham acupunctureArm 2: Standard management | - To assess the efficacy of standardised acupuncture | April 25, 2002 | June 15, 2006 |
ISRCTN18249834 c | Interventional study, parallel, randomized, non-blinded | Germany | 115 | Acupuncture | Metoprolol (100/200mg) | - Not provided | October 1, 2002 | January 31, 2005 |
ISRCTN96537534 c | Interventional study, parallel, randomized, non-blinded | United States | 401 | Acupuncture | Standard management | - Pain, wellbeing, days off work and resource use | October 1, 1998 | May 31, 2002 |
Notes: a= Recruiting, b= Active, non-recruiting, c= Completed, d = Unknown, e= terminated, N/A= not applicable
Acupuncture has been evaluated in settings of acute migraine attacks or as prophylaxis. Wang et al.22 evaluated the efficacy of traditional acupuncture for an acute migraine attack, comparing the implementation of verum versus sham acupuncture. In their study, the primary outcome was VAS reduction; where the verum acupuncture group reported a reduction of 2.4 points (baseline was 5.7 ± 1.4) and the sham acupuncture group reduction was 0.9 points (baseline was 5.4 ± 1.3), with an incidence rate of recurrence of 4–8% in both groups, with no statistical significance (p= 0.492). Li et al.23 also evaluated the impact of acupuncture in an acute migraine attack, comparing verum acupuncture with two sham groups, measuring VAS difference within the first 4 h after therapy, reporting only difference at second (p=0.032) and fourth hour (p=0.007). The verum acupuncture group baseline of 5±0.8), sham acupuncture group 1 had a baseline of 5±1.0) and sham acupuncture group 2 had baseline of 4±2.0). At fourth hour, verum acupuncture had a two points drop, sham acupuncture group 1 had a 1 point drop, and sham acupuncture group 2 had a 1.5 points drop, however there was not difference between verum and sham acupuncture at early stages of the treatment (p= 0.05), but, when second outcomes come up, verum acupuncture shows a greater effectiveness compared with sham acupuncture because at 24 hours, 40.7% of the patients had a complete resolution of pain, also 79.6% of people in this group did not experience recurrence or intensification of the pain, and over 30% rated verum acupuncture over 75% in the overall satisfaction (p<0.05), and these results are greater when compared with sham acupuncture, because only 20.3% of the patients in this group had resolution at 24 hours, and 33% less patients had permanent effects between 24 and 48 hours when compared to verum acupuncture (48 vs. 37 patients), but after 24 hours there was no significant differences (p<0.05).
Regarding prophylaxis and prevention, Alecrim-Andrade et al.24 evaluated the impact of acupuncture in migraine prevention, where they compare real versus sham acupuncture with a 6-month post-treatment follow-up. The primary endpoint was the percentage of patients with >50% reduction in migraine attack frequency each month compared with the baseline period, with a highest difference during the second month. Results, when compared between baseline and second month of treatment, showed that responders rate (headaches attack drop >50%) was 45% versus 15% (p=0.021) comparing real against sham acupuncture, but the results were not only limited to it, hours per month of headache drop 55% versus 36% (p=0.002), and the percentage of patients with reduction of 40% or more in migraine attacks were 58% versus 10% (p=0.04), but results were similar between the third month of treatment and after six months post-treatment (p=0.021). Linde et al.25 also evaluate the impact of acupuncture preventing migraine attacks, with a primary outcome of evaluating the difference in headache days of moderate or severe intensity between the 4 weeks before and weeks 9–12 after randomization. Results presented showed that both real and sham acupuncture had a very similar baseline (5.2 vs. 5.0) of VAS, with 2.2 days of headache per week (difference between acupuncture vs sham acupuncture, 0.0 days; 95%, CI, −0.7 to 0.7 days, p=0.96). Responder patients (headaches intensity drop >50%) was 51% in patients with acupuncture versus 53% in patients subjected to sham acupuncture and 15% in controls (waiting list) (p=<0.001), but, when compared the secondary outcomes, verum acupuncture was superior to sham acupuncture and controls, and there was no statistical difference in the secondary outcomes between real versus sham acupuncture (most p values >0.5, except for depression as symptom, p=0.18).
Prophylaxis was also compared with available FDA-approved drugs for chronic migraine. Chen et al.,26 performed an indirect comparison with propranolol, based on 19 papers, finding that acupuncture was significantly better than propranolol diminishing migraine episodes (SMD − 0.74, 95% CI − 1.04 to − 0.44), frequency (SMD − 0.74, 95% CI − 1.04 to − 0.44), with a safer profile than propranolol (RR 0.82, 95% CI 0.11 to 5.94), but it was not statistically significant. Giovanardi et al.,27 evaluated a total population of 1484 patients from 9 different studies, finding that acupuncture reduces the number of migraine days per month (SMD −0.37, 95% CI −1.64 to −0.11), pain intensity (SMD −0.36, 95% CI: −0.60 to −0.13) dropout rate for any reason (RR 0.39; 95% CI 0.18 to 0.84) and due to an adverse event (RR 0.26, 95% CI 0.09 at 0.74), and has a better response rate (RR: 1.46, 95% CI 1.16-1.84), results in favor of acupuncture when compared with pharmacological prophylaxis of migraine.
DiscussionAccording to NIH Consensus Development Conference on Acupuncture, it refers to acupuncture as28 “insertion of needles through the skin into underlying tissues at different depths and at strategic points on the body to produce a desired therapeutic effect”, and even it has been practiced over 3000 years, it was not only until 197929 when FDA give it the category as class III medical device and WHO included as treatment for at least 43 pathologies where it was considered as treatment in Western civilization.
Acupuncture application on migraine has been widely characterized based on the available literature. Migraine acupoints have been widely described,30 including a standard set (GB12, GB20, GB21, and Bl10), with several variations depending on the headache location and accompanying symptoms. Sham acupuncture is used as compared to real acupuncture in several studies,29 but, when it is applied, in some studies have been described a positive response to it, for example, Makary et al.31 evaluated the impact of phantom acupuncture, a novel sham acupuncture technique that reproduces the acupuncture needling procedure without somatosensory tactile stimulation. Their work was applied in lower back pain, proving through fMRI that after application of this technique, there were activation of bilateral dorsolateral/ventrolateral prefrontal cortex, with pain reduction, moreover, these findings were also documented for migraine, Li et al.32 evaluated how acupuncture (verum and sham) modify ascending and descending pathways in patients with migraine without aura, with findings including significant amplitude of low-frequency fluctuations (ALFF) increases at the left posterior insula and left putamen/caudate, and ALFF decreases in the bilateral middle occipital cortex/cuneus and bilateral rostral ventromedial medulla/trigeminocervical complex, means impacting directly in the trigeminovascular nociceptive path, showing that acupuncture directly modifies the pain matrix in the brain, findings that might be confirmed and extended by ongoing clinical studies (ChiCTR2000034417, ChiCTR2000032795, ChiCTR1900025132, ChiCTR-IOR-16008001, NCT04157192).
Acupuncture evidence is growing regarding its implementation in several conditions like migraine, supported by different medical associations that consider this therapy useful as management in acute attacks and prophylaxis of chronic migraine,33 but there are two important factors that might explain why acupuncture has been unexposed as plausible treatment, first, patient’s belief and thoughts regarding acupuncture as management of chronic conditions. Based on Mao et al.34 work, lack of communication between primary care physician and the patient, can lead to a non-use of this therapy, but also, as second reason, when the patient does not have proper address, it can lead to create unrealistic expectations of this treatment, prove of it was the systematic review made by Prady et al.,35 where they evaluated 58 papers regarding the impact of expectations in the clinical outcome of acupuncture trials, finding some evidence that pre-randomization response expectancies can show an interaction with outcomes, and, that acupuncture has increased its application, especially in conditions difficult-to treat or medically with non-specific symptoms but with high-burden use of healthcare services,36 then, a proper counseling should be addressed from primary and specialized care physicians, but also, from licensed acupuncturist, closing the gap between allopathic and traditional medicine.
Implementation of therapies in patients with chronic disease is usually expensive, especially with high-burden disease like migraine. Hansson-Hedblom et al.37 evaluate the cost-effectiveness of managing migraine in Sweden and Norway, finding that in patients with few attacks per month (0–4), costs of management is about EUR 6221 (US 7588 dollars; reference value obtained on May 27, 20:49 GMT -5:00, ET from, [https://www.ecb.europa.eu/stats/policy_and_exchange_rates/euro_reference_exchange_rates/html/eurofxref-graph-usd.en.html]), and in patients with many attacks per month (25–31) costs can rise up to EUR 57832 (US 70543 dollars). But this situation was also evaluated in low- and middle-income countries by Linde et al.,38 where they find the implementation of simple analgesics (e.g., acetylsalicylic acid) was the most cost-effective strategy for managing migraine attacks for less than US 100 dollars, but, if a triptan is needed, the incremental cost would be expected over US 10,000 dollars, and regarding prophylaxis, amitriptyline was the most cost-effective medication. Liao et al.39 evaluate acupuncture used long-term in patients with migraine and the medical expenditure, showing that acupuncture users had more outpatient visits than non-users, but they did have fewer medical expenditures (US 20,863.4 ± 102,835.3 dollars versus 17,039.6 ± 80,545.8) (p=0.01), showing that acupuncture can be a cost-effective complementary therapy in the management of migraine.
LimitationsThis scoping review has several limitations. First, there were only two databases included, Pubmed, that comprises over 32 million citations regarding biomedical literature and texts, and SCOPUS as is the largest abstract and citation database of peer-reviewed literature, both contributing to the quality of the publications chosen for this manuscript. Also, the languages evaluated were only English, Spanish, and French, which leads to show an important limitation based on the fact most of the available literature regarding acupuncture is written in Chinese, therefore, it was an impediment to acquire the available literature about this topic.
It should be mentioned that a scoping review only collects and analyzes information, but it does not evaluate the quality of the information evaluated, because it is based on a non-specific question for its design,13 and this situation is ratified by PRISMA extension.15
ConclusionsDespite of being a longstanding therapy, physiological bases of acupuncture are still poorly understood, however, based on the findings of this study, acupuncture is a safe, effective, and cost-effective therapy in the management of acute migraine attacks and also as prophylaxis for chronic migraine, but there are needed further studies to assess effectiveness with bigger populations in high-quality designed studies, as well as the results of ongoing clinical trials for increasing current knowledge and implementation of this therapy.
FundingThe authors declare they have not received funding to carry out this publication. The present publication has been self-funded.
Conflict of interestsAuthors declare to not have any conflict of interest.
We like to thank Dr. Jorge Restrepo, neurologist from the Universidad de la Sabana for his amazing support and contributions, including academic discussions and critical review of this manuscript.